Sunday, March 16.
  • Breaking News

    After delays, Teva wins approval from U.S. for migraine treatment


    Beleaguered Israeli drug company banking on Ajovy to boost sales, profits and offset the decline of its Copaxone MS treatment
    Read More

    No comments